1 / 21

in silico small molecule discovery

in silico small molecule discovery. Sales. Hit to lead. Optimise lead. Target gene. Discover hit. Clinical. Target gene identified with a viable assay . High throughput screen. i n silico. Case 1 – receptor structure known. Novel in silico hits ~ 100. dock

tavon
Download Presentation

in silico small molecule discovery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. in silico small molecule discovery Sales Hit to lead Optimise lead Target gene Discover hit Clinical Target gene identified with a viable assay High throughput screen in silico

  2. Case 1 – receptor structure known Novel in silicohits ~ 100 dock molecules into receptor Secondary assay ? hits IC50 < 10 µM Computer Database of Molecules 100,000 +

  3. How successful is this method? • From Shoichet’s group on target – protein tyrosine phosphate 1B • None of the in silico hits found by HTS • But unpredictable - other systems yielding < 1%

  4. How does one get the receptor structure? • X-ray structure available already at RCSB databank • Set up a structure determination • Predict structure

  5. X-ray crystallography pipeline Cloning Recombinant protein Expression Protein purification – mg quantities Crystallization Protein structure Electron density map X-ray diffraction pattern Protein crystals

  6. Prediction protein structure by homology Matched fold Query sequence Match sequence against library of known folds

  7. Phyre- www.sbg.bio.ic.ac.uk Phyre and predecessor 3DPSSM > 1,000 citations

  8. Case 2: Ligand activity data available Structure-activity rules Observed activity Screen Novel in silico hits database

  9. INDDExTM –A logic-based method • Muggleton & Sternberg developed a logic-based strategy • Method now incorporated into INDDEx within an Imperial spin-out Equinox Pharma • INDDEx designed to exploit availability of active and inactive data on a at least c. 5 but ideally more ligands

  10. D D C C B B B Logic-rules lead to new chemotypes 7Å C A Fragment C is bonded to fragment D Fragment B is bonded to fragment C Fragment A is 7Å from fragment B  INDDExcan learn complex rule from simpler facts 7Å A Fragment A is 7Å from fragment B which is bonded to fragment C which is bonded to fragment D

  11. D C B Rules can be understood by chemists  Standard programs: Activity = 0.45 LogP + 0.56667 Lumo +1.65 V  ILPrule: In an active molecule: Fragment A is 7Å from fragment B which is bonded to fragment C which is bonded to fragment D 7Å A

  12. Blind trial of hit discovery on GPCR-1 Data from literature 250 novel in silico hits Observed activity - From Literature INDDEx in silico at Equinox Chemistrt a Order Equinox outsourced wet chemistry and biology Test Cerep 30 Verified in vitro hits NEW CHEMOTYPES 157 Compounds

  13. GPCR-1: training set Distribution of 686 training molecules collected from public domain Actives Inactives

  14. GPCR Target 1 hits for optimatisation

  15. GPCR-1: results of primary screening True hits False hits Number of in silico hits: 157 (10µM concentration) Number of actives: 76 Number of inactives: 81 Primary screen success rate = 48%

  16. GPCR-1: new chemotypes Distribution of hits based on their diversity (Tanimoto coefficients) New chemotype

  17. Equinox hit discovery on GPCR-2 - Data from BioPrint (Cerep) INDDEx 250 novel in silico hits Observed activity - From BioPrint in silico at Equinox Chemistrt a Order Equinox outsources wet chemistry and biology Test Cerep 28 Verified in vitro hits 94 Compounds

  18. Confirmed hit rate of in silicopredictions on secondary screen c. 35%

  19. Comparative hit rates

  20. Concluding remarks • If protein structure available can initiative an in silico screening approach to find hits. • Success rate generally <.2% • X-ray structure determination requires mgs of material • Prediction of structure if sequence identity > 50% • If structure- activity data available then in silico methods can yield far better hit rates c. 35% • in silco methods complement high throughput and can find different hits

  21. In silico small molecule discovery • Michael Sternberg, Ata Amini, Paul Freemont & Michael Sternberg • Imperial CollgeLond • www.sbg.bio.ic.ac.uk & www.doc.ic.ac.uk/~shm • www.equinoxpharma.com

More Related